This clinical trial will evaluate the effectiveness and safety of a new, plant-derived ophthalmic solution in reducing or resolving signs of cataract disease in dogs. Dogs of all ages with complete mature cataracts or advanced immature cataracts in one or both eyes are eligible for screening. Dogs with chronic dry eye or uveitis are not eligible to participate in the study.
- Diagnosis of cataract disease in one or both eyes
- Owner able to administer eye drops for the duration of the study
- Ability to attend all study visits
- All study related costs are covered including study visits, blood work, ophthalmic examinations and treatment.
Please contact the VCIC at 215-573-0302 or by email at email@example.com if you would like more information about this study.